Sutro Biopharma, Inc. (STRO)

Sutro Biopharma Revenue

Sutro Biopharma had revenue of $14.52M in the quarter ending March 31, 2026, a decrease of -16.53%. This brings the company's revenue in the last twelve months to $99.61M, up 49.94% year-over-year. In the year 2025, Sutro Biopharma had annual revenue of $102.48M with 65.18% growth.

• Revenue (ttm): $99.61M
• Revenue Growth: +49.94%
• P/S Ratio: 4.94
• Revenue / Employee: $727,066
• Employees: 137
• Market Cap: 491.90M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	102.48M	40.44M	65.18%
Dec 31, 2024	62.04M	-91.69M	-59.64%
Dec 31, 2023	153.73M	85.96M	126.84%
Dec 31, 2022	67.77M	5.89M	9.52%
Dec 31, 2021	61.88M	19.16M	44.84%
Dec 31, 2020	42.72M	-14.00K	-0.03%
Dec 31, 2019	42.74M	4.32M	11.24%
Dec 31, 2018	38.42M	-13.32M	-25.75%
Dec 31, 2017	51.74M	-7.99M	-13.38%
Dec 31, 2016	59.73M	-	-

Data Source: Fiscal.ai Last updated: May 14, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 26, 2026

Data Sources Report a data error